Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD
· Real-Time Price · USD
1.20
0.01 (0.84%)
At close: Jun 24, 2025, 3:59 PM
0.84% (1D)
| Bid | 1.16 |
| Market Cap | 129.29M |
| Revenue (ttm) | 831.35M |
| Net Income (ttm) | -36.05B |
| EPS (ttm) | -1.17 |
| PE Ratio (ttm) | -1.02 |
| Forward PE | -3.8 |
| Analyst | Buy |
| Ask | 1.2 |
| Volume | 954,031 |
| Avg. Volume (20D) | 1,209,025 |
| Open | 1.19 |
| Previous Close | 1.19 |
| Day's Range | 1.13 - 1.21 |
| 52-Week Range | 0.72 - 1.80 |
| Beta | 1.32 |
About LUCD
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol LUCD
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for LUCD stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Lucid Diagnostics Inc. is scheduled to release its earnings on Aug 11, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 weeks ago
-10.07%
Lucid Diagnostics shares are trading lower after t...
Unlock content with
Pro Subscription
2 months ago
-24.24%
Lucid Dagnositcs shares are trading lower following a public offering of 12.5 million shares of common stock priced at $1.20 per share.
1 month ago · seekingalpha.com
Lucid Diagnostics Inc. (LUCD) Q1 2025 Business Update Call TranscriptLucid Diagnostics Inc. (NASDAQ:LUCD ) Q1 2025 Business Update Conference Call May 14, 2025 8:30 AM ET Company Participants Matt Riley – Senior Director-Investor Relations Lishan Aklog – Chairman and C...
